Literature DB >> 8905182

Enhancement of immunoreactivity for NF-kappa B in the hippocampal formation and cerebral cortex of Alzheimer's disease.

K Terai1, A Matsuo, P L McGeer.   

Abstract

The distribution of nuclear factor-kappa B (NF-kappa B) was investigated immunohistochemically in the hippocampal formation, entorhinal cortex, middle temporal gyrus and visual cortex of Alzheimer's disease (AD) and control postmortem cases using a polyclonal antibody against the NF-kappa B p65 subunit. In AD cases, prominent staining for NF-kappa B was seen in neurons and their processes, neurofibrillary tangles and dystrophic neurites. In control cases, only weak staining of some neurons was obtained. The neuronal staining observed in AD was strongest in the hippocampal formation and entorhinal cortex, less in the middle temporal gyrus and least in the visual cortex. There was no difference between AD and control cases in the staining of glial cells and vascular walls. These results suggest that enhanced expression of neuronal NF-kappa B occurs in areas affected by AD pathology.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8905182     DOI: 10.1016/0006-8993(96)00310-1

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  53 in total

1.  Nuclear translocation of NF-kappaB is increased in dopaminergic neurons of patients with parkinson disease.

Authors:  S Hunot; B Brugg; D Ricard; P P Michel; M P Muriel; M Ruberg; B A Faucheux; Y Agid; E C Hirsch
Journal:  Proc Natl Acad Sci U S A       Date:  1997-07-08       Impact factor: 11.205

2.  Curcumin protects dopaminergic neuron against LPS induced neurotoxicity in primary rat neuron/glia culture.

Authors:  Sufen Yang; Dan Zhang; Zhengqin Yang; Xiaoming Hu; Steven Qian; Jie Liu; Belinda Wilson; Michelle Block; Jau-Shyong Hong
Journal:  Neurochem Res       Date:  2008-03-27       Impact factor: 3.996

3.  Melatonin Rescue Oxidative Stress-Mediated Neuroinflammation/ Neurodegeneration and Memory Impairment in Scopolamine-Induced Amnesia Mice Model.

Authors:  Tahir Muhammad; Tahir Ali; Muhammad Ikram; Amjad Khan; Sayed Ibrar Alam; Myeong Ok Kim
Journal:  J Neuroimmune Pharmacol       Date:  2018-11-27       Impact factor: 4.147

Review 4.  Alzheimer's disease and type 2 diabetes via chronic inflammatory mechanisms.

Authors:  Gohar Mushtaq; Jalaluddin A Khan; Taha A Kumosani; Mohammad A Kamal
Journal:  Saudi J Biol Sci       Date:  2014-05-23       Impact factor: 4.219

5.  Trientine reduces BACE1 activity and mitigates amyloidosis via the AGE/RAGE/NF-κB pathway in a transgenic mouse model of Alzheimer's disease.

Authors:  Chun-Yan Wang; Jing-Wei Xie; Ye Xu; Tao Wang; Jian-Hui Cai; Xu Wang; Bao-Lu Zhao; Li An; Zhan-You Wang
Journal:  Antioxid Redox Signal       Date:  2013-05-03       Impact factor: 8.401

6.  Krüppel-like factor 8 ameliorates Alzheimer's disease by activating β-catenin.

Authors:  Ran Yi; Benwei Chen; Jing Zhao; Xiaorong Zhan; Liming Zhang; Xiaomin Liu; Qi Dong
Journal:  J Mol Neurosci       Date:  2013-10-11       Impact factor: 3.444

7.  Alzheimer's Pathogenesis, Metal-Mediated Redox Stress, and Potential Nanotheranostics.

Authors:  Willam T Wang; Breeya A Tailor; David S Cohen; Xudong Huang
Journal:  EC Pharmacol Toxicol       Date:  2019-06-21

Review 8.  Inflammation and programmed cell death in Alzheimer's disease: comparison of the central nervous system and peripheral blood.

Authors:  Beatrice Macchi; Francesca Marino-Merlo; Caterina Frezza; Salvatore Cuzzocrea; Antonio Mastino
Journal:  Mol Neurobiol       Date:  2014-01-21       Impact factor: 5.590

Review 9.  Signaling pathways in reactive astrocytes, a genetic perspective.

Authors:  Wenfei Kang; Jean M Hébert
Journal:  Mol Neurobiol       Date:  2011-01-14       Impact factor: 5.590

10.  Intromitochondrial IκB/NF-κB signaling pathway is involved in amyloid β peptide-induced mitochondrial dysfunction.

Authors:  Chun Shi; XiaoMing Zhu; Jisheng Wang; Dahong Long
Journal:  J Bioenerg Biomembr       Date:  2014-07-23       Impact factor: 2.945

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.